| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.583 | 0.005 | 0.583 | 5 Hydroxytryptamine antagonist | 0.54 0.006 CID_20234063 0.361 0.014 CID_1355 0.138 0.055 CID_154699959 0.343 0.015 CID_154699787 | ||
| 0.576 | 0.004 | 0.576 | 5 Hydroxytryptamine 1A agonist | 0.365 0.005 CID_20234063 0.143 0.011 CID_1355 0.536 0.004 CID_154699959 0.43 0.005 CID_154699787 | ||
| 0.57 | 0.005 | 0.717 | Alpha adrenoreceptor antagonist | 0.717 0.004 CID_20234063 0.297 0.016 CID_1355 0.119 0.047 CID_154699959 0.422 0.009 CID_154699787 | CID_20234063 | |
| 0.566 | 0.005 | 0.566 | 5 Hydroxytryptamine 2 antagonist | 0.522 0.005 CID_20234063 0.327 0.014 CID_1355 0.165 0.039 CID_154699959 0.416 0.009 CID_154699787 | ||
| 0.496 | 0.005 | 0.496 | 5 Hydroxytryptamine 2A antagonist | 0.448 0.005 CID_20234063 0.277 0.013 CID_1355 0.113 0.041 CID_154699959 0.321 0.01 CID_154699787 | ||
| 0.481 | 0.005 | 0.601 | Alpha 1 adrenoreceptor antagonist | 0.601 0.004 CID_20234063 0.262 0.014 CID_1355 0.331 0.009 CID_154699787 | CID_20234063 | |
| 0.474 | 0.006 | 0.698 | Antiadrenergic | 0.698 0.004 CID_20234063 0.33 0.012 CID_1355 0.224 0.02 CID_154699959 0.395 0.008 CID_154699787 | CID_20234063 | |
| 0.472 | 0.006 | 0.697 | Adrenaline antagonist | 0.697 0.004 CID_20234063 0.328 0.011 CID_1355 0.222 0.02 CID_154699959 0.393 0.008 CID_154699787 | CID_20234063 | |
| 0.487 | 0.04 | 0.654 | Antiobesity | 0.654 0.015 CID_20234063 0.487 0.04 CID_1355 0.51 0.035 CID_154699959 0.395 0.068 CID_154699787 | CID_20234063 | |
| 0.37 | 0.005 | 0.37 | 5 Hydroxytryptamine 1 agonist | 0.179 0.012 CID_20234063 0.141 0.015 CID_1355 0.277 0.007 CID_154699959 0.255 0.008 CID_154699787 | ||
| 0.36 | 0.007 | 0.36 | 5 Hydroxytryptamine 1A antagonist | 0.233 0.012 CID_20234063 0.204 0.014 CID_1355 0.075 0.043 CID_154699959 0.207 0.014 CID_154699787 | ||
| 0.35 | 0.006 | 0.489 | 5 Hydroxytryptamine agonist | 0.158 0.02 CID_20234063 0.489 0.005 CID_1355 0.254 0.01 CID_154699959 0.225 0.012 CID_154699787 | CID_1355 | |
| 0.337 | 0.009 | 0.337 | 5 Hydroxytryptamine 1 antagonist | 0.181 0.019 CID_20234063 0.207 0.016 CID_1355 0.072 0.052 CID_154699959 0.18 0.019 CID_154699787 | ||
| 0.333 | 0.01 | 0.377 | Dopamine antagonist | 0.133 0.029 CID_20234063 0.209 0.018 CID_1355 0.377 0.009 CID_154699787 | CID_154699787 | |
| 0.35 | 0.029 | 0.35 | Anticonvulsant | 0.206 0.079 CID_20234063 0.28 0.046 CID_1355 0.21 0.076 CID_154699959 | ||
| 0.35 | 0.039 | 0.573 | Cardiotonic | 0.573 0.009 CID_154699959 0.307 0.053 CID_154699787 | CID_154699959 | |
| 0.314 | 0.005 | 0.314 | Dopamine D3 antagonist | 0.088 0.029 CID_20234063 0.147 0.015 CID_1355 0.075 0.035 CID_154699959 0.248 0.008 CID_154699787 | ||
| 0.31 | 0.007 | 0.31 | Dopamine D4 antagonist | 0.138 0.019 CID_20234063 0.233 0.01 CID_1355 0.197 0.013 CID_154699787 | ||
| 0.304 | 0.068 | 0.314 | Spasmolytic | 0.314 0.065 CID_20234063 0.181 0.136 CID_1355 0.278 0.079 CID_154699959 0.272 0.082 CID_154699787 | CID_20234063 | |
| 0.225 | 0.005 | 0.225 | Acetylcholine M4 receptor antagonist | 0.09 0.037 CID_20234063 0.112 0.021 CID_1355 0.155 0.009 CID_154699959 0.106 0.024 CID_154699787 | ||
| 0.268 | 0.052 | 0.435 | Psychostimulant | 0.225 0.068 CID_20234063 0.435 0.018 CID_1355 0.146 0.12 CID_154699959 0.142 0.124 CID_154699787 | CID_1355 | |
| 0.216 | 0.015 | 0.224 | Alpha 2c adrenoreceptor antagonist | 0.197 0.019 CID_20234063 0.224 0.014 CID_1355 0.11 0.057 CID_154699959 0.162 0.027 CID_154699787 | CID_1355 | |
| 0.209 | 0.014 | 0.209 | Alpha 1b adrenoreceptor antagonist | 0.141 0.024 CID_20234063 0.209 0.014 CID_1355 0.131 0.026 CID_154699787 | ||
| 0.216 | 0.024 | 0.298 | 5 Hydroxytryptamine 2B antagonist | 0.13 0.052 CID_20234063 0.298 0.015 CID_1355 0.158 0.038 CID_154699787 | CID_1355 | |
| 0.205 | 0.016 | 0.311 | 5 Hydroxytryptamine 2C antagonist | 0.085 0.056 CID_20234063 0.311 0.008 CID_1355 0.128 0.033 CID_154699787 | CID_1355 | |
| 0.196 | 0.009 | 0.196 | Cannabinoid receptor antagonist | 0.088 0.035 CID_1355 0.142 0.016 CID_154699959 | ||
| 0.202 | 0.017 | 0.217 | Dopamine D2 antagonist | 0.117 0.028 CID_20234063 0.178 0.019 CID_1355 0.217 0.015 CID_154699787 | CID_154699787 | |
| 0.195 | 0.013 | 0.384 | 5 Hydroxytryptamine 7 antagonist | 0.089 0.028 CID_20234063 0.384 0.005 CID_1355 0.119 0.022 CID_154699787 | CID_1355 | |
| 0.196 | 0.017 | 0.236 | Alpha 1a adrenoreceptor antagonist | 0.125 0.028 CID_20234063 0.236 0.013 CID_1355 0.103 0.035 CID_154699787 | CID_1355 | |
| 0.178 | 0.004 | 0.437 | Peroxisome proliferator-activated receptor delta antagonist | 0.053 0.009 CID_20234063 0.437 0.002 CID_154699959 0.156 0.005 CID_154699787 | CID_154699959 | |
| 0.18 | 0.024 | 0.18 | Antihistaminic | 0.084 0.072 CID_20234063 0.108 0.049 CID_1355 | ||
| 0.23 | 0.074 | 0.356 | Cyclic AMP phosphodiesterase inhibitor | 0.215 0.083 CID_20234063 0.251 0.063 CID_1355 0.356 0.024 CID_154699959 0.18 0.111 CID_154699787 | CID_154699959 | |
| 0.173 | 0.024 | 0.173 | Histamine antagonist | 0.099 0.048 CID_1355 | ||
| 0.167 | 0.02 | 0.167 | Histamine H1 receptor antagonist | 0.119 0.033 CID_20234063 0.115 0.034 CID_1355 0.088 0.05 CID_154699787 | ||
| 0.144 | 0.008 | 0.144 | Cannabinoid CB1 receptor antagonist | 0.092 0.019 CID_1355 0.094 0.019 CID_154699959 | ||
| 0.167 | 0.033 | 0.29 | Alpha 2b adrenoreceptor antagonist | 0.179 0.029 CID_20234063 0.29 0.01 CID_1355 0.112 0.065 CID_154699787 | CID_1355 | |
| 0.214 | 0.082 | 0.345 | HERG channel blocker | 0.345 0.039 CID_1355 | CID_1355 | |
| 0.131 | 0.011 | 0.208 | Alpha 1 adrenoreceptor agonist | 0.16 0.009 CID_20234063 0.208 0.006 CID_1355 0.075 0.025 CID_154699787 | CID_1355 | |
| 0.143 | 0.024 | 0.246 | Alpha 2a adrenoreceptor antagonist | 0.142 0.024 CID_20234063 0.246 0.009 CID_1355 0.093 0.04 CID_154699787 | CID_1355 | |
| 0.123 | 0.007 | 0.213 | Vasopressin 1 antagonist | 0.104 0.009 CID_20234063 0.213 0.005 CID_154699959 0.054 0.014 CID_154699787 | CID_154699959 | |
| 0.257 | 0.148 | 0.583 | GABA C receptor rho-3 antagonist | 0.583 0.009 CID_1355 0.469 0.035 CID_154699959 | CID_1355 | |
| 0.141 | 0.04 | 0.324 | 5 Hydroxytryptamine 3A agonist | 0.324 0.003 CID_1355 | CID_1355 | |
| 0.132 | 0.033 | 0.218 | Alpha 2 adrenoreceptor antagonist | 0.111 0.04 CID_20234063 0.218 0.015 CID_1355 0.085 0.06 CID_154699787 | CID_1355 | |
| 0.115 | 0.02 | 0.173 | Alpha 1d adrenoreceptor antagonist | 0.07 0.035 CID_20234063 0.173 0.012 CID_1355 0.065 0.038 CID_154699787 | CID_1355 | |
| 0.199 | 0.105 | 0.561 | Aldehyde oxidase inhibitor | 0.172 0.122 CID_20234063 0.561 0.024 CID_1355 0.149 0.14 CID_154699959 0.203 0.103 CID_154699787 | CID_1355 | |
| 0.106 | 0.012 | 0.153 | Antidiuretic hormone antagonist | 0.09 0.014 CID_20234063 0.153 0.007 CID_154699959 0.046 0.024 CID_154699787 | CID_154699959 | |
| 0.159 | 0.069 | 0.207 | Cytidine deaminase inhibitor | 0.207 0.044 CID_1355 0.195 0.05 CID_154699959 | CID_1355 | |
| 0.113 | 0.023 | 0.248 | Alpha adrenoreceptor agonist | 0.149 0.016 CID_20234063 0.248 0.006 CID_1355 0.067 0.048 CID_154699787 | CID_1355 | |
| 0.189 | 0.103 | 0.301 | Potassium channel (Voltage-sensitive) blocker | 0.301 0.049 CID_1355 | CID_1355 | |
| 0.103 | 0.024 | 0.214 | Dopamine D1 antagonist | 0.072 0.038 CID_20234063 0.186 0.011 CID_1355 0.214 0.01 CID_154699787 | CID_154699787 | |
| 0.085 | 0.006 | 0.171 | Vasopressin 1A antagonist | 0.078 0.008 CID_20234063 0.171 0.004 CID_154699959 0.053 0.012 CID_154699787 | CID_154699959 | |
| 0.088 | 0.017 | 0.272 | Dopamine D4 agonist | 0.048 0.038 CID_20234063 0.272 0.005 CID_1355 0.053 0.032 CID_154699787 | CID_1355 | |
| 0.08 | 0.013 | 0.09 | 5 Hydroxytryptamine 4 antagonist | 0.09 0.009 CID_1355 0.049 0.04 CID_154699959 0.06 0.024 CID_154699787 | CID_1355 | |
| 0.165 | 0.099 | 0.238 | Anesthetic general | 0.238 0.056 CID_1355 0.213 0.067 CID_154699959 | CID_1355 | |
| 0.15 | 0.085 | 0.267 | Sigma receptor agonist | 0.267 0.045 CID_1355 0.12 0.115 CID_154699787 | CID_1355 | |
| 0.092 | 0.027 | 0.169 | 5 Hydroxytryptamine 1B antagonist | 0.169 0.011 CID_1355 | CID_1355 | |
| 0.066 | 0.007 | 0.125 | Angiotensin AT2 receptor antagonist | 0.125 0.003 CID_154699959 0.055 0.009 CID_154699787 | CID_154699959 | |
| 0.082 | 0.026 | 0.166 | Adrenaline uptake inhibitor | 0.066 0.038 CID_20234063 0.166 0.008 CID_1355 0.055 0.051 CID_154699787 | CID_1355 | |
| 0.066 | 0.01 | 0.11 | Vasopressin 2 antagonist | 0.083 0.008 CID_20234063 0.11 0.005 CID_154699959 0.039 0.018 CID_154699787 | CID_154699959 | |
| 0.101 | 0.05 | 0.137 | Phosphodiesterase 6D inhibitor | 0.137 0.014 CID_154699959 0.096 0.06 CID_154699787 | CID_154699959 | |
| 0.225 | 0.176 | 0.36 | Histamine release inhibitor | 0.279 0.135 CID_20234063 0.297 0.125 CID_1355 0.36 0.095 CID_154699959 0.207 0.194 CID_154699787 | CID_154699959 | |
| 0.084 | 0.035 | 0.143 | Dopamine agonist | 0.066 0.047 CID_20234063 0.143 0.016 CID_1355 0.09 0.031 CID_154699787 | CID_1355 | |
| 0.052 | 0.004 | 0.323 | Angiotensin AT1A receptor antagonist | 0.022 0.014 CID_20234063 0.323 0.002 CID_154699959 0.041 0.004 CID_154699787 | CID_154699959 | |
| 0.08 | 0.034 | 0.278 | 5 Hydroxytryptamine uptake inhibitor | 0.058 0.048 CID_20234063 0.278 0.007 CID_1355 | CID_1355 | |
| 0.083 | 0.039 | 0.121 | Lipase inhibitor | 0.121 0.018 CID_154699959 0.077 0.047 CID_154699787 | CID_154699959 | |
| 0.054 | 0.013 | 0.123 | Angiotensin AT1 receptor antagonist | 0.123 0.002 CID_154699959 0.038 0.037 CID_154699787 | CID_154699959 | |
| 0.06 | 0.021 | 0.069 | Dopamine D2 agonist | 0.054 0.024 CID_20234063 0.06 0.021 CID_1355 0.047 0.029 CID_154699959 0.069 0.017 CID_154699787 | CID_154699787 | |
| 0.055 | 0.016 | 0.09 | Dopamine D3 agonist | 0.044 0.024 CID_20234063 0.09 0.008 CID_1355 0.055 0.016 CID_154699787 | CID_1355 | |
| 0.058 | 0.02 | 0.084 | Dopamine D5 antagonist | 0.051 0.024 CID_20234063 0.053 0.023 CID_1355 0.084 0.011 CID_154699787 | CID_154699787 | |
| 0.042 | 0.005 | 0.063 | Vasopressin 1A agonist | 0.04 0.005 CID_20234063 0.063 0.002 CID_154699959 0.038 0.006 CID_154699787 | CID_154699959 | |
| 0.073 | 0.038 | 0.157 | 5 Hydroxytryptamine 3A antagonist | 0.157 0.005 CID_1355 | CID_1355 | |
| 0.278 | 0.243 | 0.477 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.477 0.045 CID_1355 0.371 0.129 CID_154699959 | CID_1355 | |
| 0.208 | 0.175 | 0.208 | Ca(v)3.3 blocker | |||
| 0.064 | 0.033 | 0.143 | Phosphodiesterase 1A inhibitor | 0.06 0.04 CID_1355 0.143 0.005 CID_154699959 | CID_154699959 | |
| 0.07 | 0.039 | 0.115 | MDM2 inhibitor | 0.115 0.004 CID_1355 | CID_1355 | |
| 0.063 | 0.035 | 0.13 | Dopamine uptake inhibitor | 0.053 0.046 CID_20234063 0.13 0.013 CID_1355 | CID_1355 | |
| 0.076 | 0.048 | 0.132 | Phosphodiesterase VI inhibitor | 0.132 0.009 CID_154699959 0.093 0.025 CID_154699787 | CID_154699959 | |
| 0.065 | 0.038 | 0.131 | Phosphodiesterase 1C inhibitor | 0.059 0.05 CID_1355 0.131 0.005 CID_154699959 | CID_154699959 | |
| 0.064 | 0.038 | 0.124 | Corticotropin releasing factor 2 receptor antagonist | 0.124 0.004 CID_1355 0.067 0.033 CID_154699959 | CID_1355 | |
| 0.039 | 0.015 | 0.14 | Angiotensin II receptor antagonist | 0.14 0.002 CID_154699959 | CID_154699959 | |
| 0.072 | 0.048 | 0.315 | 5 Hydroxytryptamine 1F antagonist | 0.315 0.005 CID_1355 | CID_1355 | |
| 0.065 | 0.042 | 0.228 | 5 Hydroxytryptamine 2A agonist | 0.228 0.004 CID_1355 | CID_1355 | |
| 0.145 | 0.124 | 0.145 | P-glycoprotein inhibitor | 0.145 0.125 CID_20234063 0.139 0.134 CID_154699787 | ||
| 0.03 | 0.014 | 0.048 | Antidiuretic hormone agonist | 0.027 0.019 CID_20234063 0.048 0.005 CID_154699959 0.026 0.021 CID_154699787 | CID_154699959 | |
| 0.199 | 0.186 | 0.199 | Beta lactamase inhibitor | 0.194 0.189 CID_154699959 | ||
| 0.043 | 0.031 | 0.124 | NMDA receptor subunit 3B antagonist | 0.124 0.008 CID_1355 0.04 0.034 CID_154699959 0.055 0.022 CID_154699787 | CID_1355 | |
| 0.06 | 0.049 | 0.136 | 5 Hydroxytryptamine 1D antagonist | 0.136 0.014 CID_1355 | CID_1355 | |
| 0.029 | 0.017 | 0.032 | DNA polymerase III inhibitor | 0.032 0.011 CID_154699959 | CID_154699959 | |
| 0.019 | 0.009 | 0.052 | Vasopressin 2 agonist | 0.016 0.013 CID_20234063 0.052 0.004 CID_154699959 0.015 0.014 CID_154699787 | CID_154699959 | |
| 0.022 | 0.014 | 0.034 | Vasopressin 1 agonist | 0.021 0.018 CID_20234063 0.034 0.005 CID_154699959 0.02 0.019 CID_154699787 | CID_154699959 | |
| 0.098 | 0.093 | 0.114 | Acetylcholine muscarinic antagonist | 0.114 0.074 CID_1355 0.104 0.086 CID_154699959 0.11 0.079 CID_154699787 | CID_1355 | |
| 0.258 | 0.258 | 0.607 | Antiinflammatory | 0.607 0.052 CID_20234063 0.483 0.095 CID_154699959 0.265 0.251 CID_154699787 | CID_20234063 | |
| 0.065 | 0.065 | 0.156 | Phospholipase D inhibitor | 0.156 0.003 CID_1355 | CID_1355 | |
| 0.03 | 0.031 | 0.037 | Purinergic P2X7 antagonist | 0.037 0.024 CID_1355 | CID_1355 | |
| 0.181 | 0.182 | 0.329 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.329 0.046 CID_1355 | CID_1355 | |
| 0.081 | 0.083 | 0.116 | DNA directed RNA polymerase inhibitor | 0.116 0.04 CID_154699959 | CID_154699959 | |
| 0.057 | 0.061 | 0.177 | Peroxisome proliferator-activated receptor gamma agonist | 0.177 0.008 CID_154699959 0.06 0.057 CID_154699787 | CID_154699959 | |
| 0.051 | 0.059 | 0.085 | Acetylcholine M5 receptor antagonist | 0.085 0.022 CID_1355 | CID_1355 | |
| 0.029 | 0.037 | 0.057 | p53 inhibitor | 0.057 0.01 CID_1355 | CID_1355 | |
| 0.05 | 0.059 | 0.124 | Phosphodiesterase 1B inhibitor | 0.124 0.009 CID_154699959 | CID_154699959 | |
| 0.009 | 0.018 | 0.072 | Angiotensin AT1B receptor antagonist | 0.072 0.002 CID_154699959 | CID_154699959 | |
| 0.028 | 0.038 | 0.097 | 5 Hydroxytryptamine 3B antagonist | 0.097 0.005 CID_1355 | CID_1355 | |
| 0.048 | 0.059 | 0.153 | 5 Hydroxytryptamine 7 agonist | 0.153 0.004 CID_1355 | CID_1355 | |
| 0.006 | 0.018 | 0.011 | Corticotropin releasing factor antagonist | 0.011 0.005 CID_154699959 | CID_154699959 | |
| 0.042 | 0.053 | 0.056 | Phosphodiesterase 6C inhibitor | 0.056 0.012 CID_154699959 | CID_154699959 | |
| 0.138 | 0.15 | 0.33 | Hypolipemic | 0.33 0.041 CID_154699959 0.146 0.141 CID_154699787 | CID_154699959 | |
| 0.027 | 0.04 | 0.082 | NMDA receptor subunit 3A antagonist | 0.082 0.011 CID_1355 | CID_1355 | |
| 0.075 | 0.089 | 0.165 | Phosphodiesterase I inhibitor | 0.165 0.015 CID_154699959 | CID_154699959 | |
| 0.029 | 0.045 | 0.057 | Somatostatin 4 agonist | 0.057 0.013 CID_1355 | CID_1355 | |
| 0.02 | 0.036 | 0.023 | 5 Hydroxytryptamine 4 agonist | 0.023 0.021 CID_1355 | CID_1355 | |
| 0.068 | 0.084 | 0.209 | NMDA receptor antagonist | 0.209 0.013 CID_1355 | CID_1355 | |
| 0.116 | 0.134 | 0.185 | Neuropeptide Y1 antagonist | 0.185 0.026 CID_1355 | CID_1355 | |
| 0.043 | 0.062 | 0.173 | 5 Hydroxytryptamine 6 antagonist | 0.173 0.005 CID_1355 | CID_1355 | |
| 0.026 | 0.047 | 0.054 | Estrogen-related receptor beta antagonist | 0.054 0.005 CID_1355 0.032 0.023 CID_154699787 | CID_1355 | |
| 0.088 | 0.11 | 0.124 | Acetylcholine antagonist | 0.124 0.067 CID_1355 | CID_1355 | |
| 0.041 | 0.063 | 0.238 | 5 Hydroxytryptamine 3 antagonist | 0.238 0.005 CID_1355 | CID_1355 | |
| 0.089 | 0.113 | 0.127 | Cholinergic antagonist | 0.127 0.068 CID_1355 | CID_1355 | |
| 0.025 | 0.05 | 0.032 | GHS receptor antagonist | 0.032 0.024 CID_154699959 | CID_154699959 | |
| 0.073 | 0.1 | 0.186 | Creatine kinase inhibitor | 0.116 0.044 CID_1355 0.186 0.013 CID_154699959 0.106 0.053 CID_154699787 | CID_154699959 | |
| 0.028 | 0.055 | 0.037 | Delayed rectifier potassium channel blocker | 0.037 0.026 CID_154699959 | CID_154699959 | |
| 0.074 | 0.106 | 0.171 | Lanosterol 14 alpha demethylase inhibitor | 0.114 0.037 CID_20234063 0.171 0.007 CID_1355 | CID_1355 | |
| 0.03 | 0.064 | 0.053 | GHS receptor agonist | 0.053 0.018 CID_154699959 | CID_154699959 | |
| 0.024 | 0.059 | 0.031 | Protein kinase C beta II inhibitor | 0.031 0.025 CID_1355 | CID_1355 | |
| 0.042 | 0.078 | 0.1 | Calcium channel T-type blocker | 0.1 0.016 CID_1355 | CID_1355 | |
| 0.047 | 0.083 | 0.129 | 5 Hydroxytryptamine 5A antagonist | 0.129 0.01 CID_1355 | CID_1355 | |
| 0.216 | 0.253 | 0.37 | Cyclophilin D inhibitor | 0.308 0.156 CID_20234063 0.37 0.109 CID_154699959 | CID_154699959 | |
| 0.015 | 0.054 | 0.038 | Acetylcholine M4 receptor agonist | 0.038 0.016 CID_1355 0.028 0.024 CID_154699959 | CID_1355 | |
| 0.011 | 0.051 | 0.025 | Corticotropin releasing factor 1 receptor antagonist | 0.025 0.013 CID_154699959 | CID_154699959 | |
| 0.03 | 0.071 | 0.058 | Purinergic P2X antagonist | 0.058 0.025 CID_1355 | CID_1355 | |
| 0.012 | 0.056 | 0.03 | CC chemokine 1 receptor antagonist | 0.03 0.013 CID_1355 | CID_1355 | |
| 0.018 | 0.064 | 0.033 | Phosphodiesterase 6B inhibitor | 0.033 0.017 CID_154699959 | CID_154699959 | |
| 0.022 | 0.069 | 0.076 | Vascular adhesion protein 1 inhibitor | 0.076 0.005 CID_1355 | CID_1355 | |
| 0.041 | 0.09 | 0.126 | 5 Hydroxytryptamine 5 antagonist | 0.126 0.011 CID_1355 | CID_1355 | |
| 0.005 | 0.054 | 0.052 | Peroxisome proliferator-activated receptor alpha antagonist | 0.052 0.008 CID_154699959 | CID_154699959 | |
| 0.015 | 0.064 | 0.023 | Phosphodiesterase 6H inhibitor | 0.023 0.018 CID_154699959 | CID_154699959 | |
| 0.015 | 0.064 | 0.023 | Phosphodiesterase 6G inhibitor | 0.023 0.018 CID_154699959 | CID_154699959 | |
| 0.047 | 0.099 | 0.117 | Benzodiazepine agonist | 0.117 0.017 CID_1355 | CID_1355 | |
| 0.095 | 0.149 | 0.163 | Diuretic | 0.135 0.09 CID_1355 0.163 0.067 CID_154699959 | CID_154699959 | |
| 0.086 | 0.141 | 0.259 | Toll-Like receptor 9 antagonist | 0.259 0.019 CID_1355 | CID_1355 | |
| 0.015 | 0.07 | 0.108 | Potassium channel small-conductance Ca-activated activator | 0.108 0.004 CID_1355 | CID_1355 | |
| 0.028 | 0.083 | 0.088 | Adenosine A2b receptor antagonist | 0.088 0.012 CID_154699959 | CID_154699959 | |
| 0.022 | 0.079 | 0.057 | Acetylcholine M1 receptor agonist | 0.057 0.023 CID_1355 | CID_1355 | |
| 0.026 | 0.084 | 0.036 | Adenosine uptake inhibitor | 0.036 0.02 CID_154699959 | CID_154699959 | |
| 0.028 | 0.087 | 0.133 | Adenosine A1 receptor antagonist | 0.133 0.018 CID_154699959 | CID_154699959 | |
| 0.016 | 0.076 | 0.04 | Acid ceramidase inhibitor | 0.04 0.004 CID_1355 | CID_1355 | |
| 0.026 | 0.09 | 0.075 | Nerve growth factor antagonist | 0.075 0.004 CID_1355 | CID_1355 | |
| 0.034 | 0.099 | 0.087 | CC chemokine receptor 2B antagonist | 0.087 0.007 CID_1355 | CID_1355 | |
| 0.065 | 0.132 | 0.081 | Ca(v)3.1 blocker | 0.081 0.057 CID_1355 | CID_1355 | |
| 0.064 | 0.132 | 0.17 | Bromodomain-containing protein 2 inhibitor | 0.17 0.005 CID_1355 | CID_1355 | |
| 0.028 | 0.097 | 0.07 | Acetylcholine muscarinic agonist | 0.07 0.027 CID_1355 | CID_1355 | |
| 0.09 | 0.161 | 0.195 | Acetylcholine M1 receptor antagonist | 0.195 0.045 CID_1355 | CID_1355 | |
| 0.033 | 0.106 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.027 CID_1355 | CID_1355 | |
| 0.033 | 0.107 | 0.05 | Heme oxygenase inhibitor | 0.05 0.013 CID_1355 | CID_1355 | |
| 0.057 | 0.131 | 0.109 | Sphingosine 1-phosphate receptor antagonist | 0.109 0.017 CID_154699959 | CID_154699959 | |
| 0.074 | 0.15 | 0.227 | Ribosomal protein S6 kinase inhibitor | 0.227 0.027 CID_1355 | CID_1355 | |
| 0.027 | 0.104 | 0.071 | CC chemokine 4 receptor antagonist | 0.071 0.009 CID_1355 | CID_1355 | |
| 0.008 | 0.085 | 0.026 | Urotensin II antagonist | 0.026 0.012 CID_1355 | CID_1355 | |
| 0.031 | 0.111 | 0.065 | Purinergic P2 antagonist | 0.065 0.043 CID_1355 | CID_1355 | |
| 0.007 | 0.088 | 0.032 | Dopamine autoreceptor agonist | 0.032 0.012 CID_1355 | CID_1355 | |
| 0.061 | 0.143 | 0.14 | Phosphodiesterase 7B inhibitor | 0.14 0.025 CID_1355 | CID_1355 | |
| 0.032 | 0.114 | 0.079 | Cytokine production stimulant | 0.079 0.005 CID_154699959 | CID_154699959 | |
| 0.027 | 0.109 | 0.092 | Adenosine A2a receptor antagonist | 0.092 0.027 CID_154699959 | CID_154699959 | |
| 0.048 | 0.131 | 0.108 | Adenosine A3 receptor antagonist | 0.108 0.023 CID_154699959 | CID_154699959 | |
| 0.024 | 0.108 | 0.066 | Dopamine transporter inhibitor | 0.066 0.022 CID_1355 | CID_1355 | |
| 0.062 | 0.147 | 0.136 | Cystathionine beta-synthase inhibitor | 0.136 0.047 CID_1355 0.115 0.062 CID_154699959 0.124 0.055 CID_154699787 | CID_1355 | |
| 0.036 | 0.124 | 0.073 | Sphingosine 1-phosphate receptor 1 antagonist | 0.073 0.017 CID_154699959 | CID_154699959 | |
| 0.04 | 0.132 | 0.109 | Bcl2 antagonist | 0.109 0.014 CID_1355 | CID_1355 | |
| 0.014 | 0.108 | 0.03 | MAP3K8 inhibitor | 0.03 0.017 CID_1355 | CID_1355 | |
| 0.021 | 0.116 | 0.063 | Bromodomain-containing protein 3 inhibitor | 0.063 0.017 CID_1355 | CID_1355 | |
| 0.031 | 0.126 | 0.06 | Parathyroid hormone antagonist | 0.06 0.011 CID_1355 | CID_1355 | |
| 0.013 | 0.109 | 0.022 | Phosphodiesterase 6A inhibitor | 0.022 0.021 CID_154699959 | CID_154699959 | |
| 0.037 | 0.136 | 0.091 | Heat shock protein 90 beta antagonist | 0.091 0.014 CID_1355 0.078 0.022 CID_154699787 | CID_1355 | |
| 0.033 | 0.137 | 0.065 | Alpha 1b adrenoreceptor agonist | 0.065 0.015 CID_1355 | CID_1355 | |
| 0.044 | 0.149 | 0.17 | Histamine N-methyltransferase inhibitor | 0.17 0.009 CID_1355 | CID_1355 | |
| 0.015 | 0.12 | 0.063 | Cyclin D3 inhibitor | 0.063 0.016 CID_1355 | CID_1355 | |
| 0.026 | 0.131 | 0.093 | Adenosine A2 receptor antagonist | 0.093 0.029 CID_154699959 | CID_154699959 | |
| 0.054 | 0.16 | 0.082 | ATPase (Vacuolar H+) inhibitor | 0.082 0.074 CID_1355 | CID_1355 | |
| 0.014 | 0.125 | 0.075 | Peroxisome proliferator-activated receptor alpha agonist | 0.075 0.02 CID_154699959 | CID_154699959 | |
| 0.092 | 0.204 | 0.223 | GABA C receptor rho-2 antagonist | 0.223 0.019 CID_1355 0.181 0.041 CID_154699959 | CID_1355 | |
| 0.025 | 0.139 | 0.103 | Histamine agonist | 0.103 0.009 CID_1355 | CID_1355 | |
| 0.015 | 0.13 | 0.044 | Estrogen-related receptor gamma antagonist | 0.044 0.004 CID_1355 | CID_1355 | |
| 0.049 | 0.167 | 0.111 | Anesthetic local | 0.111 0.074 CID_154699959 | CID_154699959 | |
| 0.023 | 0.143 | 0.076 | GABA A receptor antagonist | 0.076 0.023 CID_1355 | CID_1355 | |
| 0.101 | 0.221 | 0.286 | 3C-like protease (Human coronavirus) inhibitor | 0.286 0.015 CID_1355 | CID_1355 | |
| 0.043 | 0.162 | 0.152 | Acetylcholine agonist | 0.152 0.025 CID_1355 | CID_1355 | |
| 0.007 | 0.127 | 0.02 | Cyclin D2 inhibitor | 0.02 0.004 CID_1355 | CID_1355 | |
| 0.042 | 0.163 | 0.105 | Adrenaline agonist | 0.074 0.065 CID_20234063 0.105 0.034 CID_1355 | CID_1355 | |
| 0.121 | 0.244 | 0.488 | Superoxide dismutase inhibitor | 0.488 0.014 CID_1355 | CID_1355 | |
| 0.032 | 0.156 | 0.191 | Cyclin B3 inhibitor | 0.191 0.007 CID_1355 | CID_1355 | |
| 0.063 | 0.188 | 0.195 | Phosphodiesterase inhibitor | 0.195 0.036 CID_154699959 | CID_154699959 | |
| 0.009 | 0.136 | 0.065 | Kainate receptor 2 antagonist | 0.065 0.01 CID_1355 | CID_1355 | |
| 0.193 | 0.32 | 0.48 | 5 Hydroxytryptamine release inhibitor | 0.48 0.039 CID_1355 | CID_1355 | |
| 0.032 | 0.163 | 0.224 | 5 Hydroxytryptamine 3 agonist | 0.224 0.003 CID_1355 | CID_1355 | |
| 0.053 | 0.185 | 0.144 | GABA receptor agonist | 0.144 0.039 CID_1355 | CID_1355 | |
| 0.026 | 0.159 | 0.13 | Histamine H4 receptor antagonist | 0.13 0.004 CID_1355 | CID_1355 | |
| 0.027 | 0.16 | 0.101 | Cyclin D1 inhibitor | 0.101 0.008 CID_1355 | CID_1355 | |
| 0.054 | 0.187 | 0.097 | Polo-like kinase-1 inhibitor | 0.097 0.049 CID_1355 | CID_1355 | |
| 0.021 | 0.156 | 0.076 | GABA receptor antagonist | 0.076 0.023 CID_1355 | CID_1355 | |
| 0.054 | 0.189 | 0.207 | Protein kinase C zeta inhibitor | 0.207 0.01 CID_1355 | CID_1355 | |
| 0.049 | 0.186 | 0.309 | Ferrochelatase inhibitor | 0.098 0.073 CID_20234063 0.169 0.031 CID_1355 0.309 0.007 CID_154699959 | CID_154699959 | |
| 0.018 | 0.155 | 0.235 | 5 Hydroxytryptamine 2 agonist | 0.235 0.004 CID_1355 | CID_1355 | |
| 0.112 | 0.253 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.149 0.045 CID_1355 0.131 0.112 CID_154699959 | CID_1355 | |
| 0.013 | 0.155 | 0.029 | Thymidine phosphorylase inhibitor | 0.029 0.013 CID_1355 | CID_1355 | |
| 0.022 | 0.165 | 0.071 | Phosphodiesterase VII inhibitor | 0.071 0.034 CID_1355 | CID_1355 | |
| 0.011 | 0.154 | 0.07 | Melanin-concentrating hormone receptor 1 antagonist | 0.07 0.024 CID_1355 | CID_1355 | |
| 0.036 | 0.18 | 0.076 | Interferon inducer | 0.076 0.027 CID_154699959 | CID_154699959 | |
| 0.034 | 0.177 | 0.101 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.101 0.01 CID_1355 | CID_1355 | |
| 0.019 | 0.163 | 0.04 | Nicotinic acid receptor 1 agonist | 0.04 0.028 CID_1355 | CID_1355 | |
| 0.02 | 0.165 | 0.061 | Histamine H1 receptor agonist | 0.061 0.008 CID_1355 | CID_1355 | |
| 0.022 | 0.168 | 0.097 | Carbamoyl phosphate synthetase inhibitor | 0.097 0.021 CID_154699959 | CID_154699959 | |
| 0.054 | 0.202 | 0.171 | Electrolyte absorption antagonist | 0.171 0.013 CID_1355 0.094 0.067 CID_154699959 | CID_1355 | |
| 0.081 | 0.231 | 0.15 | Polo-like kinase-3 inhibitor | 0.15 0.084 CID_1355 | CID_1355 | |
| 0.05 | 0.202 | 0.141 | NADH dehydrogenase inhibitor | 0.141 0.02 CID_1355 0.103 0.041 CID_154699959 | CID_1355 | |
| 0.037 | 0.19 | 0.093 | Interferon agonist | 0.093 0.035 CID_154699959 | CID_154699959 | |
| 0.059 | 0.213 | 0.1 | Alpha 2d adrenoreceptor antagonist | 0.1 0.049 CID_1355 | CID_1355 | |
| 0.137 | 0.291 | 0.3 | 5 Hydroxytryptamine 3E antagonist | 0.3 0.005 CID_1355 | CID_1355 | |
| 0.059 | 0.214 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.044 CID_1355 0.084 0.051 CID_154699959 | CID_1355 | |
| 0.012 | 0.167 | 0.032 | CDK6/cyclin D3 inhibitor | 0.032 0.028 CID_1355 | CID_1355 | |
| 0.021 | 0.177 | 0.049 | Cholesterol esterase inhibitor | 0.049 0.032 CID_1355 | CID_1355 | |
| 0.005 | 0.161 | 0.052 | Histamine H4 receptor agonist | 0.052 0.004 CID_1355 | CID_1355 | |
| 0.048 | 0.205 | 0.153 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.153 0.026 CID_1355 0.092 0.063 CID_154699959 | CID_1355 | |
| 0.106 | 0.263 | 0.346 | 5 Hydroxytryptamine 1E antagonist | 0.346 0.011 CID_1355 | CID_1355 | |
| 0.003 | 0.161 | 0.019 | Integrin beta2 antagonist | 0.019 0.005 CID_1355 | CID_1355 | |
| 0.004 | 0.165 | 0.031 | AMPA 1 receptor antagonist | 0.031 0.019 CID_1355 | CID_1355 | |
| 0.025 | 0.189 | 0.073 | 5 Hydroxytryptamine 1B agonist | 0.073 0.016 CID_1355 | CID_1355 | |
| 0.024 | 0.193 | 0.086 | Phosphodiesterase 5A inhibitor | 0.086 0.035 CID_154699959 | CID_154699959 | |
| 0.024 | 0.199 | 0.175 | Nicotinic alpha4beta2 receptor antagonist | 0.175 0.005 CID_1355 | CID_1355 | |
| 0.024 | 0.201 | 0.105 | Toll-Like receptor 7 antagonist | 0.105 0.018 CID_1355 | CID_1355 | |
| 0.031 | 0.208 | 0.063 | Ca(v)3.2 blocker | 0.063 0.033 CID_1355 | CID_1355 | |
| 0.043 | 0.221 | 0.111 | Insulin receptor antagonist | 0.111 0.05 CID_1355 | CID_1355 | |
| 0.056 | 0.236 | 0.23 | Activin receptor-like kinase 2 inhibitor | 0.23 0.026 CID_1355 | CID_1355 | |
| 0.009 | 0.188 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.025 CID_1355 | CID_1355 | |
| 0.022 | 0.204 | 0.082 | Phosphodiesterase V inhibitor | 0.082 0.039 CID_154699959 | CID_154699959 | |
| 0.003 | 0.191 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 CID_1355 | CID_1355 | |
| 0.058 | 0.247 | 0.184 | Nav1.2 sodium channel blocker | 0.184 0.04 CID_1355 | CID_1355 | |
| 0.015 | 0.211 | 0.04 | AMPA 4 receptor antagonist | 0.04 0.026 CID_1355 | CID_1355 | |
| 0.006 | 0.202 | 0.035 | Cyclin E2 inhibitor | 0.035 0.015 CID_1355 | CID_1355 | |
| 0.021 | 0.217 | 0.092 | Protein kinase C beta inhibitor | 0.092 0.018 CID_1355 | CID_1355 | |
| 0.018 | 0.214 | 0.049 | Adenylate cyclase 1 inhibitor | 0.049 0.027 CID_1355 | CID_1355 | |
| 0.056 | 0.252 | 0.141 | Antibacterial (Helicobacter pylori) | 0.141 0.055 CID_1355 | CID_1355 | |
| 0.023 | 0.22 | 0.069 | CC chemokine receptor antagonist | 0.069 0.064 CID_1355 | CID_1355 | |
| 0.036 | 0.233 | 0.07 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.053 CID_154699959 | CID_154699959 | |
| 0.085 | 0.284 | 0.146 | Sphingosine 1-phosphate receptor 5 antagonist | 0.138 0.083 CID_1355 0.146 0.067 CID_154699959 | CID_154699959 | |
| 0.023 | 0.223 | 0.09 | Alpha 1L adrenoreceptor agonist | 0.09 0.003 CID_1355 | CID_1355 | |
| 0.016 | 0.217 | 0.036 | Vanilloid 4 antagonist | 0.036 0.016 CID_1355 | CID_1355 | |
| 0.056 | 0.259 | 0.234 | Toll-Like receptor antagonist | 0.234 0.02 CID_1355 | CID_1355 | |
| 0.006 | 0.208 | 0.018 | CC chemokine 9 receptor antagonist | 0.018 0.01 CID_1355 | CID_1355 | |
| 0.006 | 0.21 | 0.07 | Methionyl aminopeptidase 1 inhibitor | 0.07 0.004 CID_1355 | CID_1355 | |
| 0.019 | 0.224 | 0.123 | Neuronal nicotinic receptor antagonist | 0.123 0.017 CID_1355 | CID_1355 | |
| 0.016 | 0.225 | 0.05 | Acid-sensing ion channel blocker | 0.05 0.016 CID_1355 | CID_1355 | |
| 0.037 | 0.247 | 0.2 | Glutamate receptor antagonist | 0.2 0.025 CID_1355 | CID_1355 | |
| 0.023 | 0.233 | 0.136 | Acetylcholine nicotinic antagonist | 0.136 0.025 CID_1355 | CID_1355 | |
| 0.027 | 0.24 | 0.06 | Pregnane X receptor antagonist | 0.06 0.032 CID_1355 | CID_1355 | |
| 0.065 | 0.279 | 0.171 | Potassium channel blocker | 0.171 0.115 CID_1355 | CID_1355 | |
| 0.041 | 0.255 | 0.071 | Calcium channel P-type blocker | 0.071 0.027 CID_1355 | CID_1355 | |
| 0.043 | 0.257 | 0.138 | Nav1.3 sodium channel blocker | 0.138 0.056 CID_1355 | CID_1355 | |
| 0.009 | 0.226 | 0.048 | 5 Hydroxytryptamine 6 agonist | 0.048 0.005 CID_1355 | CID_1355 | |
| 0.013 | 0.232 | 0.027 | Complement factor 1r inhibitor | 0.027 0.015 CID_1355 | CID_1355 | |
| 0.007 | 0.227 | 0.322 | 5 Hydroxytryptamine 2C agonist | 0.322 0.003 CID_1355 | CID_1355 | |
| 0.082 | 0.303 | 0.189 | Neurotrophic factor enhancer | 0.189 0.088 CID_1355 | CID_1355 | |
| 0.015 | 0.238 | 0.205 | 5 Hydroxytryptamine 2B agonist | 0.205 0.002 CID_1355 | CID_1355 | |
| 0.098 | 0.322 | 0.307 | MAP-kinase-activated kinase 5 inhibitor | 0.307 0.026 CID_1355 | CID_1355 | |
| 0.028 | 0.252 | 0.113 | Chemokine receptor antagonist | 0.113 0.053 CID_1355 | CID_1355 | |
| 0.129 | 0.354 | 0.279 | Analgesic | 0.279 0.159 CID_1355 | CID_1355 | |
| 0.071 | 0.299 | 0.126 | Sphingosine 1-phosphate receptor 2 agonist | 0.126 0.047 CID_1355 | CID_1355 | |
| 0.035 | 0.264 | 0.09 | EphA2 antagonist | 0.09 0.087 CID_1355 | CID_1355 | |
| 0.014 | 0.243 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 CID_1355 | CID_1355 | |
| 0.079 | 0.309 | 0.197 | Succinate dehydrogenase inhibitor | 0.197 0.051 CID_1355 0.171 0.079 CID_154699959 | CID_1355 | |
| 0.152 | 0.383 | 0.323 | MAP kinase kinase 6 inhibitor | 0.323 0.114 CID_1355 | CID_1355 | |
| 0.001 | 0.233 | 0.014 | Melatonin 5 antagonist | 0.014 0.006 CID_1355 | CID_1355 | |
| 0.013 | 0.25 | 0.109 | Acetylcholine M5 receptor agonist | 0.109 0.015 CID_1355 | CID_1355 | |
| 0.087 | 0.324 | 0.18 | Thyroid hormone beta antagonist | 0.18 0.174 CID_1355 | CID_1355 | |
| 0.112 | 0.351 | 0.256 | ErbB-1 antagonist | 0.256 0.049 CID_1355 | CID_1355 | |
| 0.007 | 0.25 | 0.044 | LFA antagonist | 0.044 0.007 CID_1355 | CID_1355 | |
| 0.006 | 0.252 | 0.05 | AMPA receptor antagonist | 0.05 0.031 CID_1355 | CID_1355 | |
| 0.015 | 0.263 | 0.056 | Phenylethanolamine N methyltransferase inhibitor | 0.056 0.01 CID_1355 | CID_1355 | |
| 0.088 | 0.336 | 0.161 | Death-associated protein kinase 2 inhibitor | 0.161 0.083 CID_1355 | CID_1355 | |
| 0.03 | 0.278 | 0.115 | Urease inhibitor | 0.115 0.05 CID_1355 | CID_1355 | |
| 0.032 | 0.281 | 0.089 | Sphingomyelinase inhibitor | 0.089 0.074 CID_1355 | CID_1355 | |
| 0.06 | 0.309 | 0.171 | Transcription factor STAT6 inhibitor | 0.171 0.013 CID_1355 | CID_1355 | |
| 0.004 | 0.254 | 0.029 | NMDA receptor glycine site antagonist | 0.029 0.013 CID_1355 | CID_1355 | |
| 0.005 | 0.257 | 0.055 | Kainate receptor antagonist | 0.055 0.019 CID_1355 | CID_1355 | |
| 0.009 | 0.262 | 0.055 | Glutamate (mGluR5) agonist | 0.055 0.021 CID_1355 | CID_1355 | |
| 0.012 | 0.266 | 0.04 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 CID_1355 | CID_1355 | |
| 0.091 | 0.346 | 0.175 | Catenin beta inhibitor | 0.175 0.059 CID_1355 | CID_1355 | |
| 0.018 | 0.275 | 0.065 | Potassium channel small-conductance Ca-activated blocker | 0.065 0.015 CID_1355 | CID_1355 | |
| 0.066 | 0.328 | 0.147 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.147 0.132 CID_1355 | CID_1355 | |
| 0.006 | 0.269 | 0.032 | Fumarate hydratase inhibitor | 0.032 0.026 CID_154699959 | CID_154699959 | |
| 0.017 | 0.28 | 0.083 | CXC chemokine receptor antagonist | 0.083 0.034 CID_1355 | CID_1355 | |
| 0.013 | 0.278 | 0.065 | CC chemokine 2 receptor antagonist | 0.065 0.028 CID_1355 | CID_1355 | |
| 0.048 | 0.315 | 0.139 | Acetylcholine release stimulant | 0.139 0.024 CID_1355 | CID_1355 | |
| 0.008 | 0.276 | 0.053 | Glutamate (mGluR group I) agonist | 0.053 0.028 CID_1355 | CID_1355 | |
| 0.023 | 0.292 | 0.192 | ALK inhibitor | 0.192 0.012 CID_1355 | CID_1355 | |
| 0.008 | 0.282 | 0.084 | NMDA 2A receptor antagonist | 0.084 0.018 CID_1355 | CID_1355 | |
| 0.03 | 0.304 | 0.076 | GABA A receptor agonist | 0.076 0.07 CID_1355 | CID_1355 | |
| 0.036 | 0.311 | 0.17 | GABA C receptor rho-1 antagonist | 0.17 0.014 CID_1355 0.115 0.045 CID_154699959 | CID_1355 | |
| 0.031 | 0.306 | 0.077 | Neuropeptide Y antagonist | 0.077 0.063 CID_1355 | CID_1355 | |
| 0.101 | 0.377 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.052 CID_1355 | CID_1355 | |
| 0.045 | 0.323 | 0.342 | NADPH oxidase inhibitor | 0.342 0.008 CID_1355 | CID_1355 | |
| 0.018 | 0.297 | 0.089 | Protein kinase C alpha inhibitor | 0.089 0.028 CID_1355 | CID_1355 | |
| 0.02 | 0.3 | 0.048 | CF transmembrane conductance regulator antagonist | 0.048 0.01 CID_1355 | CID_1355 | |
| 0.06 | 0.342 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | 0.135 0.065 CID_1355 | CID_1355 | |
| 0.022 | 0.304 | 0.069 | Cathepsin G inhibitor | 0.069 0.055 CID_1355 | CID_1355 | |
| 0.051 | 0.334 | 0.142 | Mannose-6-phosphate isomerase inhibitor | 0.142 0.072 CID_1355 | CID_1355 | |
| 0.01 | 0.295 | 0.109 | Toll-Like receptor 8 antagonist | 0.109 0.007 CID_1355 | CID_1355 | |
| 0.086 | 0.372 | 0.226 | Gastrin inhibitor | 0.226 0.11 CID_1355 0.214 0.128 CID_154699959 | CID_1355 | |
| 0.015 | 0.302 | 0.049 | Transforming growth factor beta 1 antagonist | 0.049 0.035 CID_1355 | CID_1355 | |
| 0.077 | 0.367 | 0.153 | Death-associated protein kinase 1 inhibitor | 0.153 0.035 CID_1355 | CID_1355 | |
| 0.005 | 0.296 | 0.055 | Glycine transporter inhibitor | 0.055 0.028 CID_1355 | CID_1355 | |
| 0.016 | 0.309 | 0.107 | Cyclin-dependent kinase 4 inhibitor | 0.107 0.024 CID_1355 | CID_1355 | |
| 0.138 | 0.432 | 0.226 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.226 0.103 CID_1355 | CID_1355 | |
| 0.021 | 0.315 | 0.085 | Nicotinic alpha3beta2 receptor antagonist | 0.085 0.011 CID_1355 | CID_1355 | |
| 0.004 | 0.299 | 0.033 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 CID_1355 | CID_1355 | |
| 0.011 | 0.307 | 0.046 | Adenosine deaminase inhibitor | 0.046 0.034 CID_154699959 | CID_154699959 | |
| 0.028 | 0.324 | 0.124 | Bronchodilator | 0.124 0.042 CID_154699959 | CID_154699959 | |
| 0.003 | 0.3 | 0.019 | Complement factor D inhibitor | 0.019 0.011 CID_1355 | CID_1355 | |
| 0.041 | 0.337 | 0.152 | Activin receptor-like kinase 4 inhibitor | 0.152 0.028 CID_1355 | CID_1355 | |
| 0.02 | 0.317 | 0.068 | Cyclin H inhibitor | 0.068 0.03 CID_1355 | CID_1355 | |
| 0.087 | 0.386 | 0.713 | 5 Hydroxytryptamine release stimulant | 0.713 0.006 CID_1355 | CID_1355 | |
| 0.072 | 0.371 | 0.239 | Calpain 2 inhibitor | 0.239 0.157 CID_1355 | CID_1355 | |
| 0.005 | 0.307 | 0.032 | Myristoyl transferase inhibitor | 0.032 0.011 CID_1355 | CID_1355 | |
| 0.042 | 0.346 | 0.146 | Hedgehog signaling inhibitor | 0.146 0.025 CID_1355 | CID_1355 | |
| 0.053 | 0.358 | 0.329 | Interleukin agonist | 0.329 0.036 CID_1355 | CID_1355 | |
| 0.035 | 0.341 | 0.115 | Amylase inhibitor | 0.115 0.084 CID_1355 | CID_1355 | |
| 0.138 | 0.445 | 0.436 | Caspase 9 stimulant | 0.436 0.091 CID_1355 | CID_1355 | |
| 0.085 | 0.394 | 0.268 | Neuropeptide Y2 antagonist | 0.268 0.04 CID_1355 | CID_1355 | |
| 0.003 | 0.313 | 0.025 | 5 Hydroxytryptamine 1D agonist | 0.025 0.023 CID_1355 | CID_1355 | |
| 0.014 | 0.325 | 0.042 | Dipeptidyl peptidase IV inhibitor | 0.042 0.035 CID_1355 | CID_1355 | |
| 0.037 | 0.348 | 0.098 | Calcium channel (voltage-sensitive) blocker | 0.098 0.086 CID_1355 | CID_1355 | |
| 0.033 | 0.346 | 0.09 | Bile acid receptor antagonist | 0.09 0.073 CID_1355 | CID_1355 | |
| 0.075 | 0.389 | 0.259 | DNA synthesis inhibitor | 0.259 0.061 CID_1355 0.199 0.125 CID_154699959 | CID_1355 | |
| 0.011 | 0.325 | 0.061 | Nicotinic receptor alpha3 subunit antagonist | 0.061 0.019 CID_1355 | CID_1355 | |
| 0.014 | 0.329 | 0.051 | Myc inhibitor | 0.051 0.043 CID_1355 | CID_1355 | |
| 0.02 | 0.335 | 0.098 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.073 CID_1355 | CID_1355 | |
| 0.012 | 0.33 | 0.072 | Amidase inhibitor | 0.072 0.045 CID_1355 | CID_1355 | |
| 0.015 | 0.339 | 0.059 | CXC chemokine 4 receptor antagonist | 0.059 0.043 CID_1355 | CID_1355 | |
| 0.016 | 0.339 | 0.099 | Insulin like growth factor 1 antagonist | 0.099 0.042 CID_1355 | CID_1355 | |
| 0.066 | 0.391 | 0.197 | ATPase inhibitor | 0.197 0.04 CID_1355 | CID_1355 | |
| 0.033 | 0.36 | 0.102 | Vanilloid 4 agonist | 0.102 0.015 CID_1355 | CID_1355 | |
| 0.078 | 0.405 | 0.275 | Cholesterol antagonist | 0.275 0.108 CID_1355 | CID_1355 | |
| 0.013 | 0.341 | 0.069 | GABA B receptor antagonist | 0.069 0.009 CID_1355 | CID_1355 | |
| 0.047 | 0.376 | 0.085 | Transforming growth factor beta 3 antagonist | 0.085 0.049 CID_1355 | CID_1355 | |
| 0.027 | 0.357 | 0.091 | Exportin-1 inhibitor | 0.091 0.014 CID_1355 | CID_1355 | |
| 0.01 | 0.34 | 0.088 | Cyclin-dependent kinase 6 inhibitor | 0.088 0.016 CID_1355 | CID_1355 | |
| 0.021 | 0.353 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 CID_1355 | CID_1355 | |
| 0.031 | 0.364 | 0.114 | Nav1.6 sodium channel blocker | 0.114 0.105 CID_1355 | CID_1355 | |
| 0.006 | 0.341 | 0.03 | Epoxide hydrolase 1 inhibitor | 0.03 0.023 CID_1355 | CID_1355 | |
| 0.039 | 0.374 | 0.083 | MAP kinase 7 inhibitor | 0.083 0.035 CID_1355 | CID_1355 | |
| 0.016 | 0.351 | 0.053 | Dopamine beta hydroxylase inhibitor | 0.053 0.025 CID_1355 | CID_1355 | |
| 0.015 | 0.35 | 0.106 | Insulin growth factor antagonist | 0.106 0.043 CID_1355 | CID_1355 | |
| 0.011 | 0.346 | 0.042 | Poly(ADP-ribose) polymerase inhibitor | 0.042 0.036 CID_1355 | CID_1355 | |
| 0.009 | 0.346 | 0.11 | Nicotinic neuronal receptor agonist | 0.11 0.01 CID_1355 | CID_1355 | |
| 0.011 | 0.348 | 0.076 | Biliverdin reductase inhibitor | 0.076 0.028 CID_154699959 | CID_154699959 | |
| 0.005 | 0.344 | 0.17 | NMDA 2 receptor antagonist | 0.17 0.013 CID_1355 | CID_1355 | |
| 0.011 | 0.354 | 0.059 | Nicotinic alpha7 receptor agonist | 0.059 0.032 CID_1355 | CID_1355 | |
| 0.02 | 0.364 | 0.164 | Glycine receptor antagonist | 0.164 0.005 CID_1355 | CID_1355 | |
| 0.029 | 0.377 | 0.111 | GABA B receptor agonist | 0.111 0.01 CID_1355 | CID_1355 | |
| 0.101 | 0.449 | 0.279 | Tyrosine 3 hydroxylase inhibitor | 0.279 0.045 CID_1355 0.237 0.081 CID_154699959 | CID_1355 | |
| 0.022 | 0.372 | 0.09 | Myeloperoxidase inhibitor | 0.09 0.049 CID_1355 | CID_1355 | |
| 0.006 | 0.356 | 0.057 | Dopamine D5 agonist | 0.057 0.013 CID_1355 | CID_1355 | |
| 0.003 | 0.355 | 0.092 | Nicotinic alpha4 receptor agonist | 0.092 0.003 CID_1355 | CID_1355 | |
| 0.048 | 0.402 | 0.196 | Hexokinase inhibitor | 0.196 0.037 CID_1355 | CID_1355 | |
| 0.015 | 0.37 | 0.154 | Purinergic P2X4 antagonist | 0.154 0.004 CID_1355 | CID_1355 | |
| 0.021 | 0.378 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 CID_1355 | CID_1355 | |
| 0.026 | 0.384 | 0.072 | Viral attachment inhibitor | 0.072 0.069 CID_1355 | CID_1355 | |
| 0.008 | 0.366 | 0.036 | Melanocortin 1 antagonist | 0.036 0.029 CID_1355 | CID_1355 | |
| 0.011 | 0.374 | 0.036 | Protein kinase (CK2) beta inhibitor | 0.036 0.017 CID_1355 | CID_1355 | |
| 0.025 | 0.388 | 0.102 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 CID_1355 0.102 0.059 CID_154699959 | CID_154699959 | |
| 0.006 | 0.371 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 CID_1355 | CID_1355 | |
| 0.02 | 0.387 | 0.053 | Sodium/calcium exchanger inhibitor | 0.053 0.029 CID_1355 | CID_1355 | |
| 0.01 | 0.377 | 0.06 | Androgen agonist | 0.06 0.041 CID_1355 | CID_1355 | |
| 0.015 | 0.382 | 0.05 | Dipeptidyl peptidase inhibitor | 0.05 0.042 CID_1355 | CID_1355 | |
| 0.023 | 0.391 | 0.148 | Protein kinase C gamma inhibitor | 0.148 0.033 CID_1355 | CID_1355 | |
| 0.08 | 0.447 | 0.21 | RNA-directed DNA polymerase inhibitor | 0.21 0.086 CID_1355 0.191 0.113 CID_154699959 | CID_1355 | |
| 0.01 | 0.379 | 0.06 | EphB4 antagonist | 0.06 0.038 CID_1355 | CID_1355 | |
| 0.006 | 0.38 | 0.063 | Alpha 1d adrenoreceptor agonist | 0.063 0.01 CID_1355 | CID_1355 | |
| 0.05 | 0.425 | 0.183 | Pregnane X receptor agonist | 0.183 0.017 CID_1355 | CID_1355 | |
| 0.089 | 0.465 | 0.461 | Calcium channel activator | 0.461 0.009 CID_1355 | CID_1355 | |
| 0.023 | 0.399 | 0.183 | GABA C receptor antagonist | 0.183 0.017 CID_1355 0.116 0.057 CID_154699959 | CID_1355 | |
| 0.025 | 0.402 | 0.08 | Glycine receptor agonist | 0.08 0.039 CID_1355 | CID_1355 | |
| 0.012 | 0.389 | 0.168 | Acetylcholine nicotinic agonist | 0.168 0.012 CID_1355 | CID_1355 | |
| 0.03 | 0.408 | 0.109 | Cathepsin H inhibitor | 0.109 0.09 CID_1355 | CID_1355 | |
| 0.011 | 0.389 | 0.06 | Beta 1 adrenoreceptor antagonist | 0.06 0.036 CID_1355 | CID_1355 | |
| 0.014 | 0.395 | 0.059 | Epithelial sodium channel blocker | 0.059 0.03 CID_1355 | CID_1355 | |
| 0.004 | 0.385 | 0.054 | Imidazoline I1 receptor antagonist | 0.054 0.004 CID_1355 | CID_1355 | |
| 0.006 | 0.388 | 0.02 | Alpha 1a adrenoreceptor agonist | 0.02 0.018 CID_1355 | CID_1355 | |
| 0.023 | 0.408 | 0.096 | Prolactin inhibitor | 0.096 0.059 CID_154699959 | CID_154699959 | |
| 0.041 | 0.426 | 0.097 | T cell inhibitor | 0.097 0.028 CID_1355 | CID_1355 | |
| 0.007 | 0.395 | 0.09 | Nicotinic receptor alpha4 subunit antagonist | 0.09 0.01 CID_1355 | CID_1355 | |
| 0.031 | 0.424 | 0.111 | Calcium channel blocker | 0.111 0.098 CID_1355 | CID_1355 | |
| 0.006 | 0.401 | 0.112 | NMDA 2C receptor antagonist | 0.112 0.012 CID_1355 | CID_1355 | |
| 0.008 | 0.403 | 0.071 | Acyl-CoA dehydrogenase inhibitor | 0.071 0.026 CID_154699959 | CID_154699959 | |
| 0.02 | 0.417 | 0.099 | Caspase 7 inhibitor | 0.099 0.029 CID_1355 | CID_1355 | |
| 0.009 | 0.41 | 0.077 | Cyclin A1 inhibitor | 0.077 0.016 CID_1355 | CID_1355 | |
| 0.043 | 0.448 | 0.113 | Glutamate release inhibitor | 0.113 0.027 CID_1355 | CID_1355 | |
| 0.006 | 0.411 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.03 CID_1355 | CID_1355 | |
| 0.104 | 0.514 | 0.419 | 5 Hydroxytryptamine uptake stimulant | 0.419 0.011 CID_1355 | CID_1355 | |
| 0.009 | 0.423 | 0.064 | CDK4/cyclin D inhibitor | 0.064 0.033 CID_1355 | CID_1355 | |
| 0.039 | 0.456 | 0.125 | Adenylate kinase inhibitor | 0.125 0.04 CID_154699959 | CID_154699959 | |
| 0.013 | 0.43 | 0.064 | Lysine-specific demethylase 1A inhibitor | 0.064 0.023 CID_1355 | CID_1355 | |
| 0.009 | 0.427 | 0.077 | Cyclin B1 inhibitor | 0.077 0.025 CID_1355 | CID_1355 | |
| 0.007 | 0.429 | 0.065 | Cyclin B2 inhibitor | 0.065 0.027 CID_1355 | CID_1355 | |
| 0.007 | 0.429 | 0.103 | NMDA receptor glycine site agonist | 0.103 0.015 CID_1355 | CID_1355 | |
| 0.006 | 0.432 | 0.02 | Factor XIII inhibitor | 0.02 0.017 CID_1355 | CID_1355 | |
| 0.006 | 0.433 | 0.032 | CDK4/cyclin D3 inhibitor | 0.032 0.016 CID_1355 | CID_1355 | |
| 0.067 | 0.497 | 0.334 | Vasodilator, peripheral | 0.334 0.081 CID_1355 | CID_1355 | |
| 0.02 | 0.453 | 0.068 | Glutamate dehydrogenase inhibitor | 0.068 0.06 CID_154699959 | CID_154699959 | |
| 0.007 | 0.441 | 0.078 | CDK4/cyclin D1 inhibitor | 0.078 0.025 CID_1355 | CID_1355 | |
| 0.03 | 0.463 | 0.117 | Cell wall synthesis inhibitor | 0.117 0.103 CID_1355 | CID_1355 | |
| 0.066 | 0.5 | 0.191 | Neurotensin receptor agonist | 0.191 0.04 CID_1355 | CID_1355 | |
| 0.013 | 0.448 | 0.117 | Glycogen synthase kinase-3 alpha inhibitor | 0.117 0.087 CID_1355 | CID_1355 | |
| 0.004 | 0.442 | 0.03 | Calcium-sensing receptor agonist | 0.03 0.013 CID_1355 | CID_1355 | |
| 0.038 | 0.476 | 0.129 | Thiol protease inhibitor | 0.129 0.099 CID_1355 | CID_1355 | |
| 0.02 | 0.461 | 0.098 | Estrogen receptor beta antagonist | 0.098 0.069 CID_154699787 | CID_154699787 | |
| 0.004 | 0.445 | 0.066 | Glutamate (mGluR1) antagonist | 0.066 0.033 CID_1355 | CID_1355 | |
| 0.029 | 0.471 | 0.106 | Estrogen antagonist | 0.106 0.084 CID_154699787 | CID_154699787 | |
| 0.049 | 0.491 | 0.146 | MAP kinase 3 inhibitor | 0.146 0.074 CID_1355 | CID_1355 | |
| 0.011 | 0.454 | 0.065 | CDK1/cyclin B1 inhibitor | 0.065 0.054 CID_1355 | CID_1355 | |
| 0.007 | 0.452 | 0.065 | Cyclin B inhibitor | 0.065 0.026 CID_1355 | CID_1355 | |
| 0.008 | 0.454 | 0.053 | Benzodiazepine antagonist | 0.053 0.021 CID_1355 | CID_1355 | |
| 0.016 | 0.464 | 0.092 | Falcipain 3 inhibitor | 0.092 0.079 CID_1355 | CID_1355 | |
| 0.053 | 0.503 | 0.194 | Antithrombotic | 0.194 0.185 CID_1355 | CID_1355 | |
| 0.01 | 0.464 | 0.064 | Sphingosine kinase 2 inhibitor | 0.064 0.027 CID_1355 | CID_1355 | |
| 0.065 | 0.518 | 0.268 | Vasodilator, coronary | 0.268 0.117 CID_1355 | CID_1355 | |
| 0.008 | 0.464 | 0.141 | Alpha 2 adrenoreceptor agonist | 0.141 0.007 CID_1355 | CID_1355 | |
| 0.041 | 0.498 | 0.154 | Adenylate cyclase stimulant | 0.154 0.056 CID_1355 | CID_1355 | |
| 0.004 | 0.465 | 0.047 | Protein kinase (CK1) epsilon inhibitor | 0.047 0.016 CID_1355 | CID_1355 | |
| 0.017 | 0.48 | 0.124 | Potassium channel (Ca-activated) activator | 0.124 0.039 CID_1355 | CID_1355 | |
| 0.004 | 0.469 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.024 CID_1355 | CID_1355 | |
| 0.011 | 0.485 | 0.085 | NMDA receptor agonist | 0.085 0.026 CID_1355 | CID_1355 | |
| 0.003 | 0.48 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 CID_1355 | CID_1355 | |
| 0.003 | 0.482 | 0.033 | Carnitine palmitoyltransferase inhibitor | 0.033 0.026 CID_1355 | CID_1355 | |
| 0.031 | 0.511 | 0.174 | Peroxidase inhibitor | 0.174 0.067 CID_1355 | CID_1355 | |
| 0.003 | 0.487 | 0.04 | Geranyltranstransferase inhibitor | 0.04 0.038 CID_154699959 | CID_154699959 | |
| 0.005 | 0.492 | 0.083 | Nicotinic receptor alpha7 subunit antagonist | 0.083 0.016 CID_1355 | CID_1355 | |
| 0.007 | 0.495 | 0.087 | Check point kinase 1 inhibitor | 0.087 0.034 CID_1355 | CID_1355 | |
| 0.012 | 0.501 | 0.112 | Calcium antagonist | 0.112 0.039 CID_1355 | CID_1355 | |
| 0.049 | 0.538 | 0.165 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.165 0.125 CID_1355 | CID_1355 | |
| 0.006 | 0.497 | 0.049 | Alcohol oxidase inhibitor | 0.049 0.047 CID_154699959 | CID_154699959 | |
| 0.022 | 0.515 | 0.119 | Nav1.5 sodium channel blocker | 0.119 0.055 CID_1355 | CID_1355 | |
| 0.005 | 0.505 | 0.024 | Geranylgeranyltransferase inhibitor | 0.024 0.013 CID_1355 | CID_1355 | |
| 0.016 | 0.517 | 0.064 | Beta 3 adrenoreceptor antagonist | 0.064 0.045 CID_1355 | CID_1355 | |
| 0.013 | 0.513 | 0.056 | MAP kinase kinase 9 inhibitor | 0.056 0.038 CID_1355 | CID_1355 | |
| 0.005 | 0.512 | 0.045 | Dihydrofolate reductase inhibitor | 0.045 0.028 CID_1355 | CID_1355 | |
| 0.037 | 0.544 | 0.189 | DNA damaging | 0.189 0.125 CID_1355 | CID_1355 | |
| 0.036 | 0.545 | 0.222 | Focal adhesion kinase 2 inhibitor | 0.222 0.053 CID_1355 | CID_1355 | |
| 0.001 | 0.511 | 0.011 | Imidazoline I2 receptor antagonist | 0.011 0.008 CID_1355 | CID_1355 | |
| 0.021 | 0.532 | 0.171 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.171 0.12 CID_1355 | CID_1355 | |
| 0.038 | 0.552 | 0.228 | 15-Lipoxygenase inhibitor | 0.228 0.184 CID_1355 | CID_1355 | |
| 0.002 | 0.521 | 0.037 | Alpha 2a adrenoreceptor agonist | 0.037 0.004 CID_1355 | CID_1355 | |
| 0.021 | 0.543 | 0.132 | Arachidonic acid antagonist | 0.132 0.11 CID_1355 | CID_1355 | |
| 0.028 | 0.55 | 0.179 | DNA methylase inhibitor | 0.179 0.094 CID_1355 | CID_1355 | |
| 0.021 | 0.545 | 0.128 | HIV-1 integrase (Overall Integration) inhibitor | 0.128 0.035 CID_1355 | CID_1355 | |
| 0.027 | 0.553 | 0.155 | Cyclooxygenase 3 inhibitor | 0.155 0.044 CID_1355 | CID_1355 | |
| 0.002 | 0.53 | 0.053 | Nicotinic alpha4beta2 receptor agonist | 0.053 0.004 CID_1355 | CID_1355 | |
| 0.037 | 0.565 | 0.179 | Tumour necrosis factor antagonist | 0.179 0.068 CID_1355 | CID_1355 | |
| 0.013 | 0.543 | 0.114 | Sodium channel blocker | 0.114 0.092 CID_1355 | CID_1355 | |
| 0.009 | 0.54 | 0.083 | Potassium channel (Voltage-sensitive) activator | 0.083 0.082 CID_1355 | CID_1355 | |
| 0.035 | 0.568 | 0.231 | Phospholipase C inhibitor | 0.231 0.029 CID_1355 | CID_1355 | |
| 0.039 | 0.572 | 0.162 | CF transmembrane conductance regulator agonist | 0.162 0.057 CID_1355 | CID_1355 | |
| 0.01 | 0.551 | 0.139 | Sodium channel (voltage-gated) blocker | 0.139 0.063 CID_1355 | CID_1355 | |
| 0.023 | 0.564 | 0.143 | DNA methyltransferase I inhibitor | 0.143 0.111 CID_1355 | CID_1355 | |
| 0.016 | 0.559 | 0.152 | AMP-activated protein kinase stimulant | 0.152 0.027 CID_1355 | CID_1355 | |
| 0.019 | 0.568 | 0.171 | Heat shock protein 90 alpha antagonist | 0.171 0.069 CID_1355 | CID_1355 | |
| 0.023 | 0.573 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.088 CID_1355 | CID_1355 | |
| 0.005 | 0.555 | 0.122 | Pim-3 kinase inhibitor | 0.122 0.03 CID_1355 | CID_1355 | |
| 0.022 | 0.573 | 0.183 | Cyclin-dependent kinase 8 inhibitor | 0.183 0.049 CID_1355 | CID_1355 | |
| 0.016 | 0.572 | 0.149 | Beta glucuronidase inhibitor | 0.149 0.025 CID_1355 | CID_1355 | |
| 0.005 | 0.563 | 0.059 | Cyclin A2 inhibitor | 0.059 0.048 CID_1355 | CID_1355 | |
| 0.02 | 0.581 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.04 CID_1355 | CID_1355 | |
| 0.002 | 0.564 | 0.055 | Nicotinic alpha3beta4 receptor agonist | 0.055 0.004 CID_1355 | CID_1355 | |
| 0.004 | 0.569 | 0.065 | Pim-2 kinase inhibitor | 0.065 0.027 CID_1355 | CID_1355 | |
| 0.012 | 0.578 | 0.164 | Protein kinase C mu inhibitor | 0.164 0.02 CID_1355 | CID_1355 | |
| 0.018 | 0.584 | 0.12 | Toll-Like receptor 2 antagonist | 0.12 0.077 CID_1355 | CID_1355 | |
| 0.005 | 0.572 | 0.093 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.093 0.04 CID_1355 | CID_1355 | |
| 0.048 | 0.615 | 0.216 | Insulysin inhibitor | 0.216 0.134 CID_1355 | CID_1355 | |
| 0.005 | 0.576 | 0.055 | Cyclin A inhibitor | 0.055 0.048 CID_1355 | CID_1355 | |
| 0.023 | 0.597 | 0.192 | 12-Lipoxygenase inhibitor | 0.192 0.161 CID_1355 | CID_1355 | |
| 0.013 | 0.598 | 0.233 | MAP kinase kinase 2 inhibitor | 0.233 0.062 CID_1355 | CID_1355 | |
| 0.035 | 0.62 | 0.124 | DNA repair enzyme inhibitor | 0.124 0.064 CID_1355 | CID_1355 | |
| 0.019 | 0.608 | 0.139 | Heat shock protein 90 antagonist | 0.139 0.087 CID_1355 | CID_1355 | |
| 0.027 | 0.616 | 0.139 | Aurora-C kinase inhibitor | 0.139 0.066 CID_1355 | CID_1355 | |
| 0.026 | 0.616 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.092 0.041 CID_1355 | CID_1355 | |
| 0.002 | 0.596 | 0.043 | Diamine oxidase inhibitor | 0.043 0.02 CID_1355 | CID_1355 | |
| 0.012 | 0.606 | 0.199 | GABA C receptor agonist | 0.199 0.02 CID_1355 | CID_1355 | |
| 0.028 | 0.622 | 0.156 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.135 CID_154699959 | CID_154699959 | |
| 0.024 | 0.625 | 0.153 | Antipruritic | 0.153 0.091 CID_1355 | CID_1355 | |
| 0.002 | 0.608 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 CID_1355 | CID_1355 | |
| 0.025 | 0.634 | 0.062 | Prolactin release inhibitor | 0.062 0.044 CID_154699959 | CID_154699959 | |
| 0.006 | 0.617 | 0.069 | Aryl hydrocarbon receptor antagonist | 0.069 0.039 CID_1355 | CID_1355 | |
| 0.017 | 0.629 | 0.147 | Interleukin 8 antagonist | 0.147 0.036 CID_1355 | CID_1355 | |
| 0.007 | 0.62 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.014 CID_1355 | CID_1355 | |
| 0.007 | 0.624 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.014 CID_1355 | CID_1355 | |
| 0.009 | 0.628 | 0.117 | Polo-like kinase-4 inhibitor | 0.117 0.059 CID_1355 | CID_1355 | |
| 0.014 | 0.636 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.148 0.056 CID_1355 | CID_1355 | |
| 0.009 | 0.64 | 0.221 | Aryl hydrocarbon receptor agonist | 0.221 0.092 CID_1355 | CID_1355 | |
| 0.012 | 0.645 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.023 CID_1355 | CID_1355 | |
| 0.001 | 0.635 | 0.022 | Cyclin T1 inhibitor | 0.022 0.009 CID_1355 | CID_1355 | |
| 0.008 | 0.643 | 0.093 | MAP kinase kinase 1 inhibitor | 0.093 0.066 CID_1355 | CID_1355 | |
| 0.023 | 0.67 | 0.096 | Glutamate (mGluR7) agonist | 0.096 0.069 CID_1355 | CID_1355 | |
| 0.005 | 0.653 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.103 0.06 CID_1355 | CID_1355 | |
| 0.012 | 0.664 | 0.121 | Cyclin-dependent kinase 7 inhibitor | 0.121 0.084 CID_1355 | CID_1355 | |
| 0.008 | 0.666 | 0.059 | Histone deacetylase SIRT3 inhibitor | 0.059 0.054 CID_1355 | CID_1355 | |
| 0.005 | 0.67 | 0.082 | Inducible nitric-oxide synthase inhibitor | 0.082 0.059 CID_1355 | CID_1355 | |
| 0.008 | 0.676 | 0.057 | Botulinum neurotoxin type A inhibitor | 0.057 0.042 CID_1355 | CID_1355 | |
| 0.007 | 0.675 | 0.103 | Protein kinase C delta inhibitor | 0.103 0.05 CID_1355 | CID_1355 | |
| 0.02 | 0.689 | 0.101 | CDK3/cyclin E inhibitor | 0.101 0.086 CID_1355 | CID_1355 | |
| 0.005 | 0.678 | 0.036 | Integrin alpha2 antagonist | 0.036 0.026 CID_1355 | CID_1355 | |
| 0.011 | 0.685 | 0.181 | I kappa B kinase epsilon inhibitor | 0.181 0.088 CID_1355 | CID_1355 | |
| 0.059 | 0.736 | 0.222 | Nitric-oxide synthase stimulant | 0.222 0.058 CID_1355 | CID_1355 | |
| 0.01 | 0.69 | 0.134 | MAP-kinase-activated kinase inhibitor | 0.134 0.02 CID_1355 | CID_1355 | |
| 0.005 | 0.69 | 0.107 | Pim-1 kinase inhibitor | 0.107 0.051 CID_1355 | CID_1355 | |
| 0.007 | 0.694 | 0.087 | Potassium channel activator | 0.087 0.064 CID_1355 | CID_1355 | |
| 0.006 | 0.693 | 0.15 | LIM domain kinase 1 inhibitor | 0.15 0.098 CID_1355 | CID_1355 | |
| 0.008 | 0.697 | 0.12 | MAP-kinase-activated kinase 2 inhibitor | 0.12 0.02 CID_1355 | CID_1355 | |
| 0.021 | 0.712 | 0.238 | Antibacterial | 0.238 0.189 CID_1355 | CID_1355 | |
| 0.015 | 0.711 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.023 CID_1355 | CID_1355 | |
| 0.003 | 0.709 | 0.075 | Nav1.7 sodium channel blocker | 0.075 0.038 CID_1355 | CID_1355 | |
| 0.007 | 0.719 | 0.059 | I kappa B kinase 2 inhibitor | 0.059 0.048 CID_1355 | CID_1355 | |
| 0.001 | 0.722 | 0.02 | Alpha 2c adrenoreceptor agonist | 0.02 0.011 CID_1355 | CID_1355 | |
| 0.005 | 0.729 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.083 CID_1355 | CID_1355 | |
| 0.017 | 0.745 | 0.273 | Hypoxia-inducible factor 1 alpha inhibitor | 0.273 0.081 CID_1355 | CID_1355 | |
| 0.005 | 0.767 | 0.077 | I kappa B kinase inhibitor | 0.077 0.064 CID_1355 | CID_1355 | |
| 0.012 | 0.808 | 0.181 | Transcription factor STAT inhibitor | 0.181 0.166 CID_1355 | CID_1355 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |